THG Plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a THGPF research report →
Price Chart
About the company
THG Plc, a digital commerce and technology group established in Manchester, UK, in 2004 (and rebranded from THG Holdings plc in January 2021), conducts its operations across a significant global footprint including the United Kingdom, United States, and wider Europe. The company's core business revolves around several distinct e-commerce verticals: It maintains a collection of pure-play online beauty retailers like Lookfantastic, Cult Beauty, and Dermstore, which together showcase approximately 1,300 premium brands spanning skincare, haircare, cosmetics, and fragrance categories. Myprotein serves as its direct-to-consumer sports nutrition brand, offering a diverse array of products from vegan options and protein supplements to vitamins, athleisure wear, and healthy snack alternatives.
- CEO
- Matthew John Moulding
- IPO
- 2022
- Employees
- 2,670
- HQ
- Altrincham, GM, GB
Get TickerSpark's AI analysis on THGPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $768.85M
- P/E
- -6.75
- Fwd P/E
- 32.20
- PEG
- -0.05
- P/S
- 0.25
- P/B
- 1.13
- EV/EBITDA
- 13.54
- Div Yield
- 0.00%
- Gross Margin
- 36.95%
- Op Margin
- -0.98%
- Net Margin
- -3.73%
- ROE
- -16.03%
- ROIC
- -1.66%
Latest fiscal year · YoY change
- Revenue
- $1.72B-1.9%
- Gross Profit
- $630.66M-9.1%
- Op Income
- $-35,485,248
- Net Income
- $54.12M+116.6%
- EPS
- $0.04+130.0%
- OCF Growth
- -110.4%
- FCF Growth
- -192.5%
- 52W High
- $0.47
- 52W Low
- $0.47
- 50D MA
- $0.47
- 200D MA
- $0.47
- Beta
- 2.46
- RSI (14)
- 100
- Avg Volume
- 1.67K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
THG reported strong H1 26 revenue growth, a more than doubled adjusted EBITDA, and improved free cash flow, while management reiterated confidence in full-year growth and cash generation.· September 10, 2026
- Group revenue rose 7.2% to £829 million, with adjusted EBITDA of £42.8 million and improved free cash flow.
- Nutrition momentum remained strong: Myprotein sold about 58.5 million branded units in H1, up from about 37.2 million last year.
- Beauty continued gaining share, with LookFantastic and Cult Beauty up 6.7% in the UK and new channel/AI partnerships expanding reach.
- Management said cost reductions, simplification, and the Ingenuity demerger have materially improved the business model and cash profile.
- Full-year guidance stayed constructive: £25 million to £35 million of positive free cash flow, Q3 constant-currency sales growth of about 2%, and Q4 revenue growth of about 6% to 7%.
THG said H1 group revenue increased 7.2% to £829 million. Adjusted EBITDA reached £42.8 million, more than double the prior year when adjusting for the Claremont Ingredients disposal, and LTM EBITDA to June was £95.4 million. Management said free cash flow improved significantly in H1 and reaffirmed a full-year target of £25 million to £35 million of positive free cash flow. For Q3, management expects constant-currency sales growth of approximately 2%, with Q4 revenue growth expected to accelerate to approximately 6% to 7%. Myprotein is on track to sell approximately 130 million branded units for full-year 2026, and the company said the HMRC VAT claim is now expected to receive an update by the end of October 26.
Matthew Moulding framed the quarter as evidence that THG’s multi-year simplification is working, saying the group has shifted into an execution phase after selling non-core businesses, reducing headcount by approximately 25% over 18 months, and demerging Ingenuity. He emphasized that THG is now a capital-light group with two global businesses and said the company is seeing stronger profitability and cash generation without sacrificing growth. His tone was confident and assertive, particularly around Myprotein’s scale, Beauty’s digital leadership, and the potential for further asset monetization.
The call highlighted a stronger cash profile, with management saying H1 free cash flow improved materially and that capital expenditure and lease payments have fallen substantially after the Ingenuity demerger. They also said debt facilities have been refinanced through the end of 2029, leverage has come down, and cash interest costs have been lowered. Management tied the full-year cash outlook to the H1 adjusted EBITDA of £42.8 million, LTM EBITDA of £95.4 million, normal H2 working-capital inflow, and further inventory optimization initiatives.
Analysts focused on Nutrition licensing expansion, GLP-1-driven demand, AI in Beauty, and possible asset disposals. Moulding said licensing partnerships often start in one market and then expand to other territories once they prove successful, and he stressed that GLP-1 is more about educating mainstream consumers than launching a single dedicated product. On Beauty AI, management said the new beauty adviser is already seeing over 1% customer engagement and those users are 7x more likely to purchase; they also said up to half of customers research via LLMs before visiting the site, with traffic referred by LLMs up 4x. On disposals, Moulding said offers received so far have been rejected because management does not view them as fair value.
The positive case from this call is that THG is showing simultaneous revenue growth, margin expansion, and better cash generation after a multi-year restructuring. Management believes Myprotein’s scale and growth, Beauty’s strength in social and AI-driven discovery, and further licensing/channel expansion can keep momentum going. They also pointed to improving whey-market conditions and continued interest in non-core assets as additional upside.
The main risks discussed were continued softness in parts of the business, including the effect of new EU duties and phasing in own-brand sales, which weighed on Q3 trends. Nutrition margins still face pressure from the whey inflation cycle, even though management said conditions may be stabilizing. In Beauty manufacturing, U.S. dispatches were constrained by packaging delays tied to Hormuz Strait issues, and management acknowledged that disposals have not yet been completed because current bids do not meet their valuation expectations.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 59.5%
- Shares Outstanding
- 1.64B
- Float Shares
- 976.22M
Our THGPF coverage
Recent articles, reports, and earnings notes.
No research on THGPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate THGPF report →THG Outperforms Industry, Trades at a Premium: Time to Buy or Exit?
zacks.com · Sep 29
THG Plc (THGHY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Sep 10
THG Stock Trades at 2.16x Book Value: Is the Valuation Worth It?
zacks.com · Aug 25
THG Q2 Earnings Beat on Personal Lines Gains, Revenues Miss
zacks.com · Jul 29
THG Outperforms Industry, Trades Near 52-Week High: Time to Exit?
zacks.com · Jul 6
THG Outperforms Industry, Trades at a Premium: Time to Buy the Stock?
zacks.com · Jun 5
Is THG Expanding Its Motorcycle & ORV Insurance Offerings?
zacks.com · May 15
THG Plc (THGHY) Q4 2025 Earnings Call Transcript
seekingalpha.com · Mar 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.